USD 14.86 Billion
Report ID: SQMG35H2002 | Region: Global | Published Date: October, 2022 | Pages: 157
The global cell therapy market was valued at USD 14.86 Billion in 2021, and it is expected to reach a value of USD 35.95 Billion by 2028, at a CAGR of 13.45% over the forecast period (2022 - 2028).
The growing number of clinical trials for cell-based treatments is driving the cell therapy industry. As a result, there has been a significant increase in worldwide investment in research and clinical translation. The presence of government and commercial funding bodies that are continuously giving funds to assist projects at various phases of clinical trials can be linked to the growing number of ongoing clinical studies.
In addition, advances in the field of regenerative medicine are likely to lead to more effective treatment options for chronic illnesses. Several businesses in emerging areas, such as Canada, are at the vanguard, attempting to profit from the market for cell therapy's untapped potential.
Global Market Size
USD 14.86 Billion
To get more reports on the above market click here to Buy The Report
The global cell therapy market is segmented based on Use-type, Therapy Type, Product, Technology, Application, and Region. Based on Use-type it is categorized into Clinical-use, By Therapeutic Area, Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, By Cell Type, Stem Cell Therapies, BM, Blood, & Umbilical cord-derived Stem Cells, Adipose-derived cells, Non-stem Cell Therapies, Research-use. Based on Therapy Type it is categorized into Allogenic Therapies, Autologous Therapies. Based on Product it is categorized into Consumables, Equipment, Systems, and Software. Based on Technology it is categorized into Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, and Three-Dimensional Technology. Based on the region it is categorized into North America, Europe, Asia-Pacific, South America, and MEA.
Analysis by Product
The Global Cell Therapy Market is divided into three categories: consumables, equipment, and systems and software. In 2020, the consumables category held the greatest proportion of the cell therapy technologies market. Factors such as increased company investments in developing improved products, as well as government measures to improve cell-based research, are driving the growth of the cell therapy consumables market.
To get detailed analysis on other segments, Request For Sample Report
In 2020, North America is expected to have the biggest market share of 42.0%. The existence of a significant number of institutions and institutes involved in stem cell treatment research and development accounts for the region's large share. Five of the eight top colleges in the world are situated in the United States, including Stanford University's Institute for Stem Cell Biology and Regenerative Medicine, Harvard University's Harvard Stem Cell Institute, and Yale University's Yale Stem Cell Center. Over the projected period, the market for cell therapy in the Asia Pacific is expected to develop at a profitable rate. The growing investment by developers and customers in self-education for sophisticated medical therapies is expected to enhance the income generated by the region's expanding economies. In Asian nations, there are a number of stem cell consortiums whose goal is to ensure that R&D activities are well-coordinated and targeted. Furthermore, because of the legal framework's flexibility, patients from Western nations have been spotted migrating to Asian countries for treatment.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Companies are getting FDA permission for stem cell treatment for a variety of disorders and infections. For example, in September 2020, the FDA granted Stemedica Cell Technologies, Inc. Investigational New Drug permission to undertake phase II studies of intravenously delivered allogeneic MSCs in covid-19 patients. Ischemic-tolerant MSCs have various characteristics that make them an appealing potential biological treatment for COVID-19, including immunomodulatory effects, limited immunogenicity, and the ability to inhibit excessive pro-inflammatory responses.
Top Players' Company Profiles
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyses the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our analysis, cell-based therapies have the potential to replace, repair, restore, or regenerate damaged tissues and organs. Researchers are investing heavily in the development of such effective and safe treatments as an alternative to conventional treatment strategies, which is attributed to market growth. The timely delivery of therapies to patients at required clinical sites is one of the most pressing issues confronting market participants. Furthermore, the administration of these therapeutics poses a number of post-pandemic challenges. Hospitals are hesitant to provide services due to concerns about SARS-CoV-2 transmission, particularly to vulnerable individuals.
|Market size value in 2021||USD 14.86 Billion|
|Market size value in 2028||USD 35.95 Billion|
|Forecast period||2022 - 2028|
|Forecast Unit (Value)||USD Billion|
|Regions covered||North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)|
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Cell Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Cell Therapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Cell Therapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Cell Therapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.SPEAK TO AN ANALYST
Get lifetime access to our reportsBasic Plan $5,000 Team Plan $10,000 SUBSCRIBE NOW
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.
Product ID: SQMG35H2002